ADCY10 and esophageal cancer: Among others, SAC was described to prevent cells growth, suppress invasive growth, and inhibit proliferation in the LA-N-5 human neuroblastoma cell line [46], prostate, ovarian nasopharyngeal and esophageal cancer cell lines [47], as well as hepatocellular carcinoma MHCC97 cell model [48].